Klinik Ottakring — Vienna, State of Vienna

Public research footprint of Klinik Ottakring, compiled from the ClinicalTrials.gov public registry.

Registered studies

Active

Recruiting now

Completed

Most-studied conditions

Parkinson's Disease (PD) · Multiple Myeloma · PD-L1-positive, Locally Advanced (Unresectable Stage IIIB/C) or… · Extensive-stage Small Cell Lung Cancer (ES-SCLC)

Recently updated registry entries

NCT06635824 — Trial to Evaluate Acasunlimab and Pembrolizumab Combination Superiority Over Standard of… (Active Not Recruiting)
NCT06158841 — Study Assessing Activity of Intravenous (IV) Etentamig Monotherapy Versus Standard… (Recruiting)
NCT06208150 — A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Klinik Ottakring?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 05, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.